Skip to content

Physical and Health Outcomes With ExeRcise in Cancer SURVIVORS

Effect of an Exercise Program on Physical Performance and Health Outcomes in Cancer Survivors

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06547853
Acronym
POWERSurviv
Enrollment
30
Registered
2024-08-09
Start date
2024-07-01
Completion date
2025-07-31
Last updated
2024-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Female, Exercise

Keywords

Cancer Survivors, Breast Cancer, Physical Exercise

Brief summary

This study aims to evaluate the effect of a physical exercise intervention model on breast cancer survivors and their adherence. The sample will consist of 30 women with a primary diagnosis of breast cancer. The intervention will be carried out in a highly complex oncology center in Maceió-AL, Brazil, using the FITT components of the prescription: frequency (4 days a week), intensity (aerobic part through musical beats, subjective perception scale and resistance exercises through the number of maximum repetitions), the total time of each session will be 45 minutes. The intervention arms include combined exercise training and aerobic exercise (i.e., walking). Adherence to each intervention evaluated in the 12-week intervention cycle will be measured in each session.

Detailed description

The study participants will be enrolled in a visit to a group of psychologic therapy women cancer survivors who met monthly and who have submitted to breast cancer treatment in a hospital in the city of Maceió (AL), Brazil, classified as High Complexity Oncologic Clinic. At this visit, the proposal for physical exercises will be presented in the hospital area. Volunteers will be scheduled for an in-person visit and assessed for eligibility. Those who meet all the inclusion/exclusion criteria will be invited to integrate the physical exercise intervention. The 12-week exercise intervention will consist of a combined exercise including an aerobic component (dance) and resistance training, and aerobic exercise (i.e., walking). Participants will be evaluated pre- and post-intervention in terms of several health indicators. All ethical approvals were collected before study initiation.

Interventions

BEHAVIORALPhysical exercise

Groups will be enrolled in a 12-week exercise program. The intervention will be carried out in a highly complex oncology center in Maceió-AL, using the FITT components of the prescription: frequency (4 days a week), intensity (aerobic part through musical beats, subjective perception scale and resistance exercises through a number of maximum repetitions), the time of each session will be 45 minutes, the type of activity offered will be combined exercise training and aerobic exercise training (i.e., walking).

Sponsors

Federal University of Alagoas
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

1. Women; 2. Adults; 3. confirmed diagnostic of breast cancer and with treatment completed (surgery, radiotherapy, or chemotherapy) within the previous six months.

Exclusion criteria

1. present metastatic breast cancer; 2. any clinical condition that would make participating in the exercise intervention impossible.

Design outcomes

Primary

MeasureTime frameDescription
Exercise adherence12-weeks interventionTotal adherence will be expressed by the percentage of attendance by each participant in the total exercise intervention length. This will be measured by the study staff as the participants presence in each session.

Secondary

MeasureTime frameDescription
Change in cardiorespiratory fitness12-weekscardiorespiratory fitness will be evaluated through the 6-minutes walk test
Change in depression total score12-weeksDepression will be evaluated using the 9-Item Patient Health Questionnaire (PHQ-9) total score
Change in systolic and diastolic blood pressure12-weeksBlood pressure is going to be measured after 10 minutes in a seated position. Mean Systolic blood pressure and diastolic blood pressure will be evaluated through a digital wrist monitor.
Change in Health-related Quality of Life total score12-weeksHealth-related quality of life will be evaluated through the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30)
Change in Sleep quality12-weeksSleep quality will be evaluated using the The Pittsburgh Sleep Quality Index (PSQI)
Change in pain total score12-weeksPain will be evaluated using the Brief Pain Inventory (BPI) total score

Countries

Brazil

Contacts

Primary ContactJean Toscano, PhD
jean.toscano@hotmail.com+55 82988311415

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026